Ramón Zapata

Ramón Zapata has been appointed as the new Chief Financial Officer of BioNTech, succeeding Jens Holstein. With a background in the pharmaceutical industry, including a role at Novartis, Zapata is expected to lead the company's financial strategies as it focuses on expanding its oncology portfolio and developing innovative cancer therapies.